 |
 |
 |
|
|
The purpose of this website is to provide information about a receptor specific, growth hormone secretagogue called sermorelin
that provides an important alternative to recombinant growth hormone
for treating age-related or acquired growth hormone insufficiency.
Unlike hGH, Sermorelin affects a more primary source
of age-failure in the GH neuroendocrine axis, has more physiological
activity and better safety profile.
Please explore this website to learn more about using Sermorelin.
| |
|
 |
|
 | |
|
|
|
|
|
 |
SERMORELIN BENEFITS: A BETTER ALTERNATIVE TO hGH
Human growth hormone produced by recombinant gene technology has been
used extensively for anti-aging therapy during the past decade.
Although effective in restoring certain youthful characteristics in
aging subjects, hGH has certain medical and legal issues that sometimes
restrict practitioners use of the product. The major problems with hGH
include:
- Improper dosing can lead to side effects that may be serious in some patients,
- Subcutaneous
administration results in non-physiological or "square wave" exposure
of tissues to hGH that is not controlled by normal feedback mechanisms
and thus, eventually leads to tachyphylaxis and reduced efficacy,
- The
Code of Federal Regulations (CFR) restricts the use of hGH in adults
except for treatment of AIDS or human growth hormone deficiency (GHD)
diagnosed according to specifically published guidelines.
Based upon these potential problems with hGH, an alternative
product that overcomes the medical and legal issues would be of
significant value to anti-aging practitioners. The only such product
currently available commercially is a structural analog of human growth
hormone releasing hormone called growth hormone releasing factor (GRF)
or SERMORELIN. Unlike recombinant hGH which stimulates production of
the bioactive hormone IGF-1 from the liver, SERMORELIN simulates the
patients own pituitary gland by binding to specific receptors that
increase production and secretion of endogenous hGH. Because SERMORELIN
increases endogenous hGH by stimulating the pituitary gland it has
certain advantages over hGH that include:
- It's
effects are regulated at the level of the pituitary gland by negative
feedback and by release of somatostatin so that overdoses of hGH are
difficult if not impossible to achieve,
- Tissue exposure
to hGH released by the pituitary under the influence of SERMORELIN is
episodic not "square wave" preventing tachphylaxis by mimicking normal
physiology
- By stimulating the pituitary it preserves more
of the growth hormone neuroendocrine axis that is the first to fail
during aging.
- Pituitary recrudescence resulting from
SERMORELIN blocks the cascade of hypophyseal hormone failure that
occurs during aging thereby preserving not only youthful anatomy but
also youthful physiology,
To learn more about this new and effective product for sustaining health, vitality and good quality of life
in your patients and for access to the product, please contact Dr. Richard F. Walker
(www.richardfwalker.com) who is renowned for his expertise in
neuroendocrinology and is available to answer any technical questions
that you may have about SERMORELIN. |
| |
|
|
|
| |
